4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0000899243-16-033178
Director sold 13,730 shares at $11.03 ($151,498)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Canaan IX L.P. Director | 2016-11-09 | Sale | −13,730 | $11.03 | $151,498 | 3,930,651 | I |
| Open-market sales · 13,730 sh · avg $11.03 · $151,498 | |||||||
Loading xslF345X03/doc4.xml…